•The gut microbiota-enteric nervous system axis: from bidirectional programming to precision therapeutics in digestive diseases
•Evaluation of electroacupuncture acupoint selection's potential in the treatment of inflammatory bowel disease: an investigation using a mouse gut microbiome and metabolomics model
•Gut microbiota metabolites in inflammatory bowel disease: advances in mechanistic insights
•Identification of oxidative stress-associated biomarkers for inflammatory bowel disease through integrated machine learning and weighted gene co-expression network analysis
•ANGPT1-GABARAP axis modulates NLRP3 inflammasome-mediated pyroptosis in Crohn's disease
